Results 21 to 30 of about 3,079,392 (308)

Effects of resveratrol in ınflammatory arthritis

, 2007
Inflammation, Vol. 30, Nos. 1Y2, April 2007 ( 2006)Summary: Nuclear factor kappa B (NF-kB), is a pivotal transcription factor involved in the activation of the TNF-a and IL-1b genes.
Baysal, Özlem, Esenkaya, İrfan, Mızrak, Bülent, Elmalı, Nurzat, Harma, Ahmet   +4 more
core   +1 more source

Anti-hyperalgesic and anti-inflammatory activity of Alternanthera maritima extract and 2″-O-α-L-rhamnopyranosylvitexin in mice

, 2015
Alternanthera maritima are used in Brazilian popular medicine for the treatment of inflammatory and infectious diseases. Species of Alternanthera have demonstrated biological activities in previous scientific studies.
Arena, Arielle Cristina [UNESP], Aquino, Diana Figuereido de Santana, Salvador, Marcos José, Kassuya, Candida Aparecida Leite, Piccinelli, Ana Claudia, Arena, Arielle Cristina, Soares, Fabíola Lacerda Pires   +6 more
core   +1 more source

Low grade chronic inflammation and anti-inflammatory diet: effect on Rheumatoid arthritis [PDF]

, 2023
openThis work focus on what low grade inflammation is and how this human health condition can be detected and which effect has on human health. How nutrition can be usefull to control or improve inflammation through a specific diet and how the diet must ...
BAZZAN, NICOLÒ
core  

Heparanase in inflammation and inflammation‐associated cancer [PDF]

The FEBS Journal, 2013
Recent years have seen a growing body of evidence that enzymatic remodeling of heparan sulfate proteoglycans profoundly affects a variety of physiological and pathological processes, including inflammation, neovascularization, and tumor development. Heparanase is the sole mammalian endoglycosidase that cleaves heparan sulfate.
Amichay, Meirovitz, Rachel, Goldberg, Adi, Binder, Ariel M, Rubinstein, Esther, Hermano, Michael, Elkin   +5 more
openaire   +2 more sources

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen, Calogero Virgone, Antje Redlich, Michael Abele, Ricardo Lopez‐Almaraz, Tal Ben‐Ami, Ewa Bien, Gianni Bisogno, Maja Mazic Cesen, Andrea Ferrari, Malgorzata A. Krawczyk, Yves Reguerre, Dominik T. Schneider, Ines B. Brecht, Charlotte Rigaud, Bilgehan Yalcin, Rainer Claus, Christian Vokuhl, Constantin Lapa, Jörg Fuchs, Segolene Hescot, Thomas Walter, Julien Hadoux, Daniel Orbach   +23 more
wiley   +1 more source

Early Body Mass Index z‐Score Change and Resolution of Severe Malnutrition in Children With Sickle Cell Anemia in a Low‐Income Setting: A Prospective Single‐Arm Extension Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with sickle cell anemia (SCA) in low‐income settings are at risk of severe malnutrition, but optimal nutritional management has not been established. We evaluated an intensified ready‐to‐use therapeutic food (RUTF) regimen in children with persistent severe malnutrition after initial treatment and assessed whether early ...
Safiya Gambo, Shehu Umar Abdullahi, Hassan Adam Murtala, Halima Kabir, Khadija A. Shamsu, Sari A. Acra, Virginia A. Stallings, Mark Rodeghier, Michael R. DeBaun, Lauren J. Klein   +9 more
wiley   +1 more source

Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids

Pediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz, Se Whee Sammy Park, Aironas Los, Ernest Liu, Nona Struyf, Tom Erkers, Sören Lehmann, Jan J. Molenaar, Jakob Stenman, Olli Kallioniemi, Päivi Östling, Brinton Seashore‐Ludlow, Kasper Karlsson   +12 more
wiley   +1 more source

Endotoxemia-induced inflammation and the effect on the human brain [PDF]

, 2010
Introduction: Effects of systemic inflammation on cerebral function are not clear, as both inflammation-induced encephalopathy as well as stress-hormone mediated alertness have been described.Methods: Experimental endotoxemia (2 ng/kg Escherichia coli ...
Verbeek, M., Hoedemaekers, C.W.E., Boogaard, Mark van den, Sieberen P van der Werf, Hoeven, J.G. van der, van der Werf, Sieberen P., Boogaard, M.H.W.A. van den, Lisette Schoonhoven, Ramakers, Bart P., Nens van Alfen, Johannes G van der Hoeven, Schoonhoven, L., Wilhelmina F Fick, Schoonhoven, Lisette, Marcel M Verbeek, Pickkers, P., van der Hoeven, Johannes G., Bart P Ramakers, Peter Pickkers, Alfen, N. van, Hoedemaekers, Cornelia W., Hoeven, Hans van der, Fick, Wilhelmina F., Ramakers, B.P.C., Van den Boogaard, Mark, Fick, W.F., Hoedemaekers, A., Fick, I., Mark van den Boogaard, Werf, S.P. van der, Verbeek, Marcel M., Cornelia W Hoedemaekers, Pickkers, Peter, van Alfen, Nens, Ramakers, B., Werf, S. van der, Verbeek, M.M.   +36 more
core   +2 more sources

Kidney Inflammation, Injury and Regeneration 2020

, 2021
Acute kidney injury (AKI) is still associated with high morbidity and mortality incidence rates, and also bears an elevated risk of chronic kidney disease in the sequel.

core   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source